Form 4: Dolby Laboratories Executive Sells Shares Acquired Through Employee Stock Purchase Plan
Insider Transaction Report
Mark Andrew Sherman, EVP, General Counsel & Secretary of Dolby Laboratories, Inc., sold 350 shares of Class A Common Stock for $74.97 per share, acquired through the company's Employee Stock Purchase Plan.
Summary
- Mark Andrew Sherman, the Executive Vice President, General Counsel, and Secretary of Dolby Laboratories, Inc. (DLB), reported a sale of company stock.
- The transaction involved the disposition of 350 shares of Class A Common Stock.
- The shares were sold at a price of $74.97 per share.
- The sale occurred on May 30, 2025.
- These 350 shares were acquired under the Issuer's Employee Stock Purchase Plan (ESPP) on May 15, 2025.
- Following this transaction, Mr. Sherman beneficially owns 62,397 shares of Class A Common Stock, which includes 45,470 shares underlying restricted stock units subject to vesting and forfeiture.
- The transaction was made pursuant to a Rule 10b5-1(c) plan, indicating a pre-arranged sale plan.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. While an insider sale can be seen as negative, the small amount, the fact it's from an ESPP, and the 10b5-1 plan context suggest it's a routine financial management action rather than a signal of negative company prospects.
Positives
- The transaction was conducted under a Rule 10b5-1(c) plan, which suggests a pre-planned sale rather than a reaction to new information, often viewed positively as it reduces the perception of opportunistic trading.
- The shares sold were recently acquired through an Employee Stock Purchase Plan (ESPP), which is a common mechanism for employees to monetize a portion of their compensation or investment.
Negatives
- An insider selling shares, even a small amount, can sometimes be perceived as a slight negative signal, though in this case, it appears to be a routine disposition of ESPP shares.
Future Outlook
This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.
Industry Context
This filing is a routine insider transaction disclosure and does not provide broader industry context or trends. It reflects an individual executive's share activity rather than a strategic company announcement.
Stakeholder Impact
- Shareholders: The sale of a relatively small number of shares by an executive, especially under a 10b5-1 plan and from an ESPP, is unlikely to have a significant direct impact on existing shareholders. It's a routine disclosure of executive compensation monetization.
Key Dates
| Date | Description |
|---|---|
| 05/15/2025 | Date shares were acquired under the Issuer's Employee Stock Purchase Plan. |
| 05/30/2025 | Date of the reported transaction (sale of shares). |
| 06/03/2025 | Date the Form 4 was signed by the Attorney-in-Fact for Mark Andrew Sherman. |
Recommendation
holdKeywords
Dolby Laboratories, DLB, SEC Form 4, Insider Trading, Stock Sale, Employee Stock Purchase Plan, ESPP, Mark Andrew Sherman, Corporate Governance, Executive Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.